PARTICIPA

PARTICIPA

miércoles, 2 de noviembre de 2022

Cardiovascular and renal efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients without diabetes: a systematic review and meta-analysis of randomised placebo-controlled trials | BMJ Open


No hay comentarios:

Publicar un comentario

Danos tu opinion, enriquece el post.